Home › Idiopathic Thrombocytopenic Purpura › District of Columbia › Washington
Idiopathic Thrombocytopenic Purpura clinical trials in Washington, DC
6 studies for Idiopathic Thrombocytopenic Purpura are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
RecruitingPhase 1/2
- MedStar Georgetown University Hospital, Washington D.C.
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- Georgetown University Medical Center - Lombardi Comprehensive Cancer Center, Washington D.C.
- American Oncology Partners of Maryland, PA, Bethesda · 7 mi away
Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia
RecruitingPhase 2
- Georgetown University Medical Center, Washington D.C.
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- Georgetown University Medical Center - Lombardi Comprehensive Cancer Center, Washington D.C.
OM336 in Autoimmune Cytopenias
RecruitingPhase 1
- Medstar, Washington D.C.
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
RecruitingPhase 3
- Georgetown University Hospital, Washington D.C.
Idiopathic Thrombocytopenic Purpura trials in other cities
- Los Angeles, CA7 studies
- Greenville, NC6 studies
- Boston, MA6 studies
- The Bronx, NY5 studies
- Durham, NC4 studies
- Rochester, MN4 studies
- Seattle, WA4 studies
- Houston, TX4 studies
- Portland, OR4 studies
- Cleveland, OH3 studies
- Cedar Rapids, IA3 studies
- New Haven, CT3 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.